Ying Hon Sze

Title: Innovations in Refractive Disorder Treatment by Ying Hon Sze

Introduction

Ying Hon Sze is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of ophthalmology, particularly in the treatment of refractive disorders. His innovative approach focuses on targeting the peroxisome proliferator-activated receptor (PPAR) signaling pathway.

Latest Patents

Ying Hon Sze holds 1 patent for his work titled "Treating refractive disorders by targeting peroxisome proliferator-activated receptor (PPAR) signaling pathway." This patent describes a pharmacologic treatment for refractive disorders, specifically myopia and hyperopia. The method involves using a PPARγ agonist that does not bind to PPARα. His research demonstrates that the PPARγ agonist can modulate ocular growth through therapeutic intervention at the protein level of the PPAR signaling pathway. The effectiveness of this agonist has been validated through experiments using a lens-induced myopia (LIM) animal model. Furthermore, it has been shown that the pharmacological reduction of myopic eye growth can be achieved with a dosage effect through the administration of the PPARγ agonist.

Career Highlights

Throughout his career, Ying Hon Sze has worked with esteemed organizations such as the Centre for Eye and Vision Research Limited and The Hong Kong Polytechnic University. His work has significantly advanced the understanding and treatment of refractive disorders.

Collaborations

Ying Hon Sze has collaborated with notable colleagues, including Chuen Lam and Yan Yin Tse. Their combined efforts have contributed to the success of his research and innovations in the field.

Conclusion

Ying Hon Sze's innovative work in treating refractive disorders through the PPAR signaling pathway represents a significant advancement in ophthalmology. His contributions continue to influence the field and offer hope for improved treatments for myopia and hyperopia.